phenyl acetate has been researched along with riluzole in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrus, PK; Cutting, FB; Doble, A; Gurney, ME; Hall, ED; Taylor, CP; Zhai, P | 1 |
| Miller, RG | 2 |
| Forshew, DA | 1 |
| Bernardi, G; Caramia, MD; Desiato, MT; Iani, C; Palmieri, MG; Scalise, A; Telera, S | 1 |
| Itzhak, Y; Martin, JL | 1 |
| Armon, C | 1 |
| Banasr, M; Behar, KL; Chowdhury, GM; Duman, RS; Newton, SS; Sanacora, G; Terwilliger, R | 1 |
| Chow, DS; Grossman, RG; Sarkar, M; Toups, EG | 1 |
3 review(s) available for phenyl acetate and riluzole
| Article | Year |
|---|---|
Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.
Topics: Acetates; Adolescent; Adult; Amines; Amyotrophic Lateral Sclerosis; Animals; Brain-Derived Neurotrophic Factor; Child; Child, Preschool; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Glutamic Acid; Guidelines as Topic; Humans; Infant; Insulin-Like Growth Factor I; Male; Mice; Middle Aged; Motor Neuron Disease; Muscular Atrophy, Spinal; Nerve Growth Factors; Outcome Assessment, Health Care; Postpoliomyelitis Syndrome; Riluzole | 1999 |
Therapeutic advances: new hope for patients with ALS.
Topics: Acetates; Aged; Amines; Amyotrophic Lateral Sclerosis; Cyclohexanecarboxylic Acids; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Long-Term Care; Neuroprotective Agents; Patient Education as Topic; Riluzole | 1998 |
How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression?
Topics: Acetates; Amines; Amyotrophic Lateral Sclerosis; Anticonvulsants; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Disease Progression; Gabapentin; gamma-Aminobutyric Acid; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Neuroprotective Agents; Quality of Life; Riluzole; Sickness Impact Profile | 1999 |
1 trial(s) available for phenyl acetate and riluzole
| Article | Year |
|---|---|
Pharmacologic reversal of cortical hyperexcitability in patients with ALS.
Topics: Acetates; Amines; Amyotrophic Lateral Sclerosis; Cerebral Cortex; Cyclohexanecarboxylic Acids; Diazepam; Drug Therapy, Combination; Evoked Potentials, Motor; Female; GABA Agonists; GABA Modulators; Gabapentin; gamma-Aminobutyric Acid; Humans; Magnetics; Male; Middle Aged; Neural Inhibition; Neuroprotective Agents; Physical Stimulation; Riluzole; Synaptic Transmission; Treatment Outcome | 2000 |
5 other study(ies) available for phenyl acetate and riluzole
| Article | Year |
|---|---|
Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
Topics: Acetates; Amines; Amyotrophic Lateral Sclerosis; Animals; Brain; Cyclohexanecarboxylic Acids; Diet; Disease Progression; Gabapentin; gamma-Aminobutyric Acid; Humans; Mice; Mice, Transgenic; Oxidative Stress; Riluzole; Spinal Cord; Superoxide Dismutase; Survival Analysis; Thiazoles; Vitamin E | 1996 |
New approaches to therapy of amyotrophic lateral sclerosis.
Topics: Acetates; Amines; Amyotrophic Lateral Sclerosis; Animals; Brain-Derived Neurotrophic Factor; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Insulin-Like Growth Factor I; Mice; Riluzole | 1998 |
Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice.
Topics: Acetates; Amines; Animals; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Cyclohexanecarboxylic Acids; Dopamine Uptake Inhibitors; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Male; Methamphetamine; Mice; Motor Activity; Riluzole; Time Factors | 2000 |
Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole.
Topics: Acetates; Animals; Avoidance Learning; Behavioral Symptoms; Depression; Disease Models, Animal; Food Preferences; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutamic Acid; Isotopes; Magnetic Resonance Spectroscopy; Male; Neuroglia; Neuroprotective Agents; Prefrontal Cortex; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Riluzole; RNA, Messenger; Statistics, Nonparametric; Stress, Psychological; Sucrose; Sweetening Agents | 2010 |
UPLC-MS/MS assay of riluzole in human plasma and cerebrospinal fluid (CSF): Application in samples from spinal cord injured patients.
Topics: Acetates; Biological Assay; Calibration; Cerebrospinal Fluid; Chromatography, High Pressure Liquid; Humans; Limit of Detection; Liquid-Liquid Extraction; Plasma; Reproducibility of Results; Riluzole; Spectrometry, Mass, Electrospray Ionization; Spinal Cord; Spinal Cord Injuries; Tandem Mass Spectrometry | 2017 |